CEU’s Center for Ethics and Law in Biomedicine (CELAB) hosted the third mobilization and mutual learning session (MML) of the NERRI (Neuro-enhancement, Responsible Research and Innovation) Project on September 26. The purpose of this meeting was to seek preliminary inspiration and analysis from scientific stakeholders in order to clarify the project's understanding of the responsibility and role of researchers. The workshop was opened by Professor Judit Sandor, founding director of CEU’s Center for Ethics and Law in Biomedicine (CELAB), who summarized the current stage of the NERRI Project and the purpose of the event.
The first presentation was given by Professor Csaba Pleh, founder and chair of the Department of Cognitive Science at the Budapest University of Technology and Economics, who gave a presentation on “Neural plasticity: Psychological interpretations.” He was followed by Professor Andras Dinnyes, professor at Szent Istvan University, Budapest and founder director of BioTalentum Ltd, who spoke about “Stem cell therapy for neurodegenerative diseases – possibilities and barriers.” Dinnyes argued that stem cell research provides a unique opportunity for testing the effect of drugs on neural systems. Adam Takacs, faculty in the Department of Cognitive Psychology at Eotvos Lorand University in Budapest, rounded off the discussion with his talk on “Identifying at risk groups of ADHD.” Takacs commented on the difficulties of choosing samples in research on Attention Deficit Hyperactivity Disorder (ADHD). The presentations were followed by a lively expert panel discussion with members Zoltan Nusser, Dezso Nemeth, Imre Szebik, CELAB fellows and members of the audience. The discussion was moderated by Marton Varju.